Stocks Health care PMN
NASDAQ · Health careProMIS Neurosciences Inc. (PMN)
It posted a net loss of $42.2M. At June 30, 2026 it held $53.4M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 13, 2026.
Key facts about ProMIS Neurosciences Inc.
- Net worth
- ProMIS Neurosciences Inc. has a market value (market cap) of $35.7M at the latest share price, and shareholders' equity of $49.4M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Cash flow
- In fiscal 2025 operations used $28.1M of cash.
- Latest report
- The latest periodic report (quarterly report, 10-Q) was filed with the SEC on August 13, 2026 and covers the period to June 30, 2026. Open on SEC EDGAR
- Next earnings report
- ProMIS Neurosciences Inc.'s next report is expected around November 11, 2026. That is an estimate from its filing rhythm, not a date the company has announced.
What ProMIS Neurosciences Inc. does
ProMIS Neurosciences Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker PMN.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | n/a | -$39.7M | -$22.61 | n/a |
| 2024 | n/a | $2.8M | $2.63 | n/a |
| 2023 | n/a | -$13.2M | -$25.58 | n/a |
| 2022 | n/a | -$18.1M | -$57.62 | -$17M |
| 2022 | n/a | -$9.8M | -$40.41 | -$9.3M |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Latest SEC filings
What ProMIS Neurosciences Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- August 14, 2026Passive stake changed SCHEDULE 13G/A
- August 13, 2026Passive stake changed SCHEDULE 13G/A
- August 13, 2026
- August 13, 2026
- August 13, 2026Passive stake changed SCHEDULE 13G/A
- July 28, 2026
- May 29, 2026
- May 20, 2026
- May 15, 2026Passive stake (5% or more) SCHEDULE 13G
- May 15, 2026Passive stake (5% or more) SCHEDULE 13G
Insider trades
What the people running ProMIS Neurosciences Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.
Insiders bought $134.7K worth of shares on the open market in the last 90 days and sold none.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| November 4, 2026 | Williams EugeneDirector | Bought | 26,500 | $90.9K |
| November 2, 2026 | Cashman NeilChief Scientific Officer, Director | Bought | 10,000 | $38.6K |
| October 30, 2026 | Williams EugeneDirector | Bought | 1,316 | $5.3K |
| August 5, 2026 | Kaplan JohanneChief Development Officer | Bought | 2,280 | $30.3K |
| April 22, 2026 | Kirwin Patrick D.Director | Boughtindirect | 4,000 | $45.3K |
| March 5, 2026 | Williams EugeneDirector | Bought | 2,000 | $48.8K |
| March 4, 2026 | Williams EugeneDirector | Bought | 2,000 | $48K |
| March 3, 2026 | Williams EugeneDirector | Bought | 1,000 | $21.9K |
Who owns PMN
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Fan Yu13D, may seek influence with 8 related filers | 17% | February 5, 2026 |
| Jeremy M. Sclar13G, passive with 2 related filers | 16.9% | October 15, 2025 |
| Janus Henderson Group PLC13G, passive | 14.4% | April 7, 2026 |
| Shaf QIC LLC13G, passive with 1 related filers | 10.01% | July 31, 2025 |
| Deep Track Capital, LP13G, passive with 3 related filers | 9.99% | February 6, 2026 |
| Trails Edge Capital Partners, LP13G, passive with 2 related filers | 9.9% | February 10, 2026 |
| Wellington Biomedical Innovation Master Investors (Cayman) II, L.P.13G, passive | 7.8% | August 13, 2026 |
| Wellington Management Group LLP13G, passive with 3 related filers | 7.8% | August 13, 2026 |
| Sphera Funds Management Ltd.13G, passive with 2 related filers | 7.78% | February 5, 2026 |
| Great Point Partners, LLC13G, passive with 2 related filers | 7.66% | August 14, 2026 |
Largest institutional holders
Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 27 managers reported a position.
| Holder | Shares | Change on quarter |
|---|---|---|
| Jupiter Topco LLC | 1,292,757 | new |
| Deep Track Capital, LP | 835,655 | 0 |
| Wellington Management Group Llp | 696,378 | 0 |
| Ally Bridge Group (NY) LLC | 620,319 | +206,100 |
| Trails Edge Capital Partners, LP | 557,103 | 0 |
| Woodline Partners LP | 441,911 | +46,616 |
| Yu Fan | 329,760 | 0 |
| Sphera Funds Management Ltd. | 325,591 | 0 |
| Squadron Capital Management LLC | 324,977 | 0 |
| Ikarian Capital, LLC | 205,000 | +150,000 |
| Ameriprise Financial Inc | 185,700 | new |
| Adage Capital Partners GP, L.L.C. | 164,275 | +25,000 |
| 683 Capital Management, LLC | 95,000 | +2,150 |
| ADAR1 Capital Management, LLC | 92,850 | -2,500 |
| Great Point Partners LLC | 86,150 | -285,252 |
| Boothbay Fund Management, LLC | 62,078 | +46,035 |
| Millennium Management LLC | 56,045 | -21,876 |
| Bank of Montreal | 11,371 | new |
| Seven Fleet Capital Management LP | 10,600 | 0 |
| Morgan Stanley | 7,559 | new |
Insiders
7 insiders reported holding 1,032,558 shares in total, about $4.1M at the last price.
| Holder | Shares |
|---|---|
| ABG Management Ltd.Director, 10% owner | 943,090943,090 held indirectly |
| Williams EugeneDirector | 40,213 |
| Cashman NeilChief Scientific Officer, Director | 18,6544,122 held indirectly |
| Kirwin Patrick D.Director | 9,7884,653 held indirectly |
| Milbury Max A.Principal Accounting Officer | 8,409 |
| Kaplan JohanneChief Development Officer | 6,221 |
| Warma Neil KChief Executive Officer, Director | 6,183 |
Questions about PMN
What does ProMIS Neurosciences Inc. do?
ProMIS Neurosciences Inc. is a company in the Health care sector, listed on NASDAQ as PMN. Its shares trade on NASDAQ under the ticker PMN.
What is ProMIS Neurosciences Inc.'s net worth?
ProMIS Neurosciences Inc. has a market value (market cap) of $35.7M at the latest share price, and shareholders' equity of $49.4M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is ProMIS Neurosciences Inc. profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $42.2M.
When did ProMIS Neurosciences Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 13, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the insider trade from November 6, 2026.
When is ProMIS Neurosciences Inc.'s next earnings report?
ProMIS Neurosciences Inc.'s next report is expected around November 11, 2026. That is an estimate from its filing rhythm, not a date the company has announced.
Similar companies
Compare PMN with
Follow PMN
Get an email when ProMIS Neurosciences Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values ProMIS Neurosciences Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.